Clinical Professor of Applied Clinical Science in the Department of Pharmacy Practice and Sciences, College of Pharmacy, University of Iowa (50% appointment) and Clinical Pharmacy Specialist, IRB Reviews, Drug Information Center, Department of Pharmaceutical Care, University of Iowa Healthcare (30% appointment). I completed my B.Sc. in Pharmacy from the University of Iowa in 1976, my M.Sc. in Hospital/Clinical Pharmacy in 1978, my residency at the V.A. Medical Center in Iowa City in 1978 and my Ph.D. in Pharmacokinetics in 1992 also from the University of Iowa.
My current research emphasis is helping students discover the skills and knowledge they need to become future pharmacy practitioners and researchers. A major focus of my efforts is to expose these mentees to the role of safe medical research through the review and approval of all proposed research that involves medications being used in humans.
In the past my research primarily focused on descriptive pharmacokinetics; using traditional statistical approaches and neural networks to predict pharmacokinetics. During my service in the Burn Treatment Center I had numerous opportunities to investigate altered pharmacokinetics in the hypermetabolic burn population.
II am involved in helping students discover the skills and knowledge they need to become future pharmacy practitioners and researchers. A major focus of my efforts is to expose these mentees to the role of safe medical research through the review and approval of all proposed research that involves medications being used in humans. I conduct a pharmacist review on behalf of the Pharmacy & Therapeutics Committee for all research that will be conducted at the UIHC that will involve medications being used in human subjects. Students and residents are exposed to the research process from the design and safety perspective and how this might impact pharmacy.
I review, on the average, 16 new research protocols each month (range 9-25 per month). I spend about 2.1 hours on each review (range 1-4 hours), with the shorter ones having been first reviewed by the Holden Comprehensive Cancer Center. I no longer participate in the Institutional Review Board (IRB) meetings that approve all research projects that will involve human subjects. In addition I review and approve approximately 24 IRB research proposals per month that require a modification. This is a 14% increase in the number of new protocols reviewed each month and an increase of 28% for the modifications that are done each month. The goal is to provide these consultative services and develop a clerkship experience that will generate interest and skills for students who will pursue research in their future residency or faculty appointments.
A portion of my time is also spent providing back-up coverage in the hospital drug information center when the current staff member is on leave or is away from the center on other business and creatively through the development of drug information applications for mobile devices. There is also regular interaction with the residents that provide DI and MUE services. I provide an advanced practice experience in an underserved country one rotation cycle per year. I have taken students to Ethiopia, Kenya, Nicaragua and Belize in past years.